Hong Kong's Prenetics agrees $1.25b SPAC merger
Hong Kong-based genetic testing business Prenetics has agreed to merge with a special purpose acquisition company (SPAC) sponsored by Adrian Cheng, scion of local property developer New World Development and managing partner of C Ventures, at an enterprise valuation of $1.25 billion.
Prenetics has raised $85 million in funding to date, including a $40 million round led by Alibaba Group’s Hong Kong Entrepreneur Fund and Beyond Ventures in 2017, and a $15 million round led by Apis...
More on Greater China
Latest News
Novo Tellus hits $375m first close on third Indo-Pacific fund
Novo Tellus Capital Partners, an investor in industrial technology assets across the Indo-Pacific region, has reached a first close of approximately USD 375m on its third fund – matching the overall target for the vehicle.
Matrix, HongShan back China's Qihan Biotech
Matrix Partners China and HongShan (formerly Sequioa Capital China) have joined a USD 16m pre-Series B round for Qihan Biotech, a genome editing player active in human and agricultural therapies.
Trifecta closes third India venture debt fund on $214m
Trifecta Capital has closed its third India venture debt fund with about INR 17.8bn (USD 214) in commitments. The initial target was INR 10bn with a greenshoe option of INR 5bn.
ShawKwei commits $34m to US EV battery manufacturer
Asia-focused industrial technology investor ShawKwei & Partners has announced its third investment in a US-based company in three weeks, with a USD 34.3m commitment to battery manufacturer Group14 Technologies.